Overview
Xinlei Hao practices practicing medicine in Wuhan, China.
Hao is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Central Serous Chorioretinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Endophthalmitis.
They are actively involved in clinical research, co-authoring 22 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xinlei Hao
Is Xinlei Hao a top-rated expert for Central Serous Chorioretinopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Xinlei Hao is classified as an Advanced expert for Central Serous Chorioretinopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xinlei Hao participate in research or clinical trials?
Yes. Xinlei Hao has published 22 articles and abstracts on conditions like Central Serous Chorioretinopathy. You can view a list of Xinlei Hao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Central Serous Chorioretinopathy
- Experienced
- Age-Related Macular Degeneration (ARMD)
- EndophthalmitisHao isExperienced. Learn about Endophthalmitis.
- Late-Onset Retinal Degeneration